Gül A - Search Results

1

Low-dose natural human interferon-alpha lozenges in the treatment of Behçet's syndrome.

Kiliç H, Zeytin HE, Korkmaz C, Mat C, Gül A, Coşan F, Dinç A, Simşek I, Süt N, Yazici H. Kiliç H, et al. Among authors: gul a. Rheumatology (Oxford). 2009 Nov;48(11):1388-91. doi: 10.1093/rheumatology/kep237. Epub 2009 Aug 28. Rheumatology (Oxford). 2009. PMID: 19717547 Clinical Trial.

2

Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease.

Gül A, Ozbek U, Oztürk C, Inanç M, Koniçe M, Ozçelik T. Gül A, et al. Br J Rheumatol. 1996 Nov;35(11):1178-80. doi: 10.1093/rheumatology/35.11.1178. Br J Rheumatol. 1996. PMID: 8948311

3

Organizing pneumonia associated with pulmonary artery aneurysms in Behçet's disease.

Gül A, Yilmazbayhan D, Büyükbabani N, Lie JT, Tunaci M, Tunaci A, Inanç M, Ocal L, Aral O, Koniçe M. Gül A, et al. Rheumatology (Oxford). 1999 Dec;38(12):1285-9. doi: 10.1093/rheumatology/38.12.1285. Rheumatology (Oxford). 1999. PMID: 10587562 No abstract available.

4

Lack of association of HLA-B*51 with a severe disease course in Behçet's disease.

Gül A, Uyar FA, Inanc M, Ocal L, Tugal-Tutkun I, Aral O, Koniçe M, Saruhan-Direskeneli G. Gül A, et al. Rheumatology (Oxford). 2001 Jun;40(6):668-72. doi: 10.1093/rheumatology/40.6.668. Rheumatology (Oxford). 2001. PMID: 11426025

5

Prevalence of Behçet's disease in Istanbul, Turkey.

Azizlerli G, Köse AA, Sarica R, Gül A, Tutkun IT, Kulaç M, Tunç R, Urgancioğlu M, Dişçi R. Azizlerli G, et al. Among authors: gul a. Int J Dermatol. 2003 Oct;42(10):803-6. doi: 10.1046/j.1365-4362.2003.01893.x. Int J Dermatol. 2003. PMID: 14521694

6

Expression of KIR and C-type lectin receptors in Behcet's disease.

Saruhan-Direskeneli G, Uyar FA, Cefle A, Onder SC, Eksioglu-Demiralp E, Kamali S, Inanç M, Ocal L, Gül A. Saruhan-Direskeneli G, et al. Among authors: gul a. Rheumatology (Oxford). 2004 Apr;43(4):423-7. doi: 10.1093/rheumatology/keh063. Epub 2003 Dec 16. Rheumatology (Oxford). 2004. PMID: 14679294

7

Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases.

Kamali S, Cefle A, Sayarlioglu M, Gul A, Inanc M, Ocal L, Aral O, Konice M. Kamali S, et al. Among authors: gul a. Rheumatol Int. 2005 Apr;25(3):211-4. doi: 10.1007/s00296-003-0422-0. Epub 2004 Jan 14. Rheumatol Int. 2005. PMID: 14722731

8

Treatment of recurrent perforating intestinal ulcers with thalidomide in Behçet's disease.

Sayarlioglu M, Kotan MC, Topcu N, Bayram I, Arslanturk H, Gul A. Sayarlioglu M, et al. Among authors: gul a. Ann Pharmacother. 2004 May;38(5):808-11. doi: 10.1345/aph.1D524. Epub 2004 Mar 9. Ann Pharmacother. 2004. PMID: 15010523

9

Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behçet's disease.

Duymaz-Tozkir J, Yilmaz V, Uyar FA, Hajeer AH, Saruhan-Direskeneli G, Gül A. Duymaz-Tozkir J, et al. Among authors: gul a. J Rheumatol. 2005 Jan;32(1):93-7. J Rheumatol. 2005. PMID: 15630732

10

Behçet's disease as an autoinflammatory disorder.

Gül A. Gül A. Curr Drug Targets Inflamm Allergy. 2005 Feb;4(1):81-3. doi: 10.2174/1568010053622894. Curr Drug Targets Inflamm Allergy. 2005. PMID: 15720240 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

946 results

Search Page